These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 8400919

  • 1. Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy.
    Ke HZ, Jee WS, Zeng QQ, Li M, Lin BY.
    Bone Miner; 1993 Jun; 21(3):189-201. PubMed ID: 8400919
    [Abstract] [Full Text] [Related]

  • 2. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats.
    Ma YF, Li XJ, Jee WS, McOsker J, Liang XG, Setterberg R, Chow SY.
    Bone; 1995 Dec; 17(6):549-54. PubMed ID: 8835309
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin E2 prevents ovariectomy-induced cancellous bone loss in rats.
    Ke HZ, Li M, Jee WS.
    Bone Miner; 1992 Oct; 19(1):45-62. PubMed ID: 1422305
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin E2 enhances cortical bone mass and activates intracortical bone remodeling in intact and ovariectomized female rats.
    Jee WS, Mori S, Li XJ, Chan S.
    Bone; 1990 Oct; 11(4):253-66. PubMed ID: 2242291
    [Abstract] [Full Text] [Related]

  • 5. Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain.
    Yao W, Jee WS, Zhou H, Lu J, Cui L, Setterberg R, Liang T, Ma Y.
    Bone; 1999 Dec; 25(6):697-702. PubMed ID: 10593415
    [Abstract] [Full Text] [Related]

  • 6. Skeletal effects of constant and terminated use of risedronate on cortical bone in ovariectomized rats.
    Li QN, Liang NC, Huang LF, Wu T, Hu B, Mo LE.
    J Bone Miner Metab; 1999 Dec; 17(1):18-22. PubMed ID: 10084397
    [Abstract] [Full Text] [Related]

  • 7. Prostaglandin E2 (PGE2) and risedronate was superior to PGE2 alone in maintaining newly added bone in the cortical bone site after withdrawal in older intact rats.
    Ma YF, Lin BY, Jee WS, Lin CH, Chen YY, Ke HZ, Li XJ.
    J Bone Miner Res; 1997 Feb; 12(2):267-75. PubMed ID: 9041060
    [Abstract] [Full Text] [Related]

  • 8. S-ketoprofen inhibits tenotomy-induced bone loss and dynamics in weanling rats.
    Zeng QQ, Jee WS, Ke HZ, Wechter WJ.
    Bone Miner; 1993 Jun; 21(3):203-18. PubMed ID: 8400920
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Loss of prostaglandin E2-induced extra cortical bone after its withdrawal in rats.
    Jee WS, Ke HZ, Li XJ.
    Bone Miner; 1992 Apr; 17(1):31-47. PubMed ID: 1581704
    [Abstract] [Full Text] [Related]

  • 12. Anabolic responses of an adult cancellous bone site to prostaglandin E2 in the rat.
    Ito H, Ke HZ, Jee WS, Sakou T.
    Bone Miner; 1993 Jun; 21(3):219-36. PubMed ID: 8400921
    [Abstract] [Full Text] [Related]

  • 13. Intermittent on/off prostaglandin E2 and risedronate are equally anabolic as daily PGE2 alone treatment in cortical bone of ovariectomized rats.
    Ma YF, Pan Z, Jee WS, Lin CH, Liang HH, Chen H, Pun S, Li XJ.
    J Bone Miner Res; 1997 Dec; 12(12):2108-12. PubMed ID: 9421244
    [Abstract] [Full Text] [Related]

  • 14. Risedronate pretreatment does not hamper the anabolic effects of prostaglandin E2 in ovx rats.
    Li QN, Jee WS, Ma YF, Ke HZ, Xie H, Huang LF, Liang NC.
    Bone; 1995 Oct; 17(4 Suppl):261S-266S. PubMed ID: 8579926
    [Abstract] [Full Text] [Related]

  • 15. Production of new trabecular bone in osteopenic ovariectomized rats by prostaglandin E2.
    Mori S, Jee WS, Li XJ.
    Calcif Tissue Int; 1992 Jan; 50(1):80-7. PubMed ID: 1739875
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats.
    Li M, Jee WS, Ke HZ, Tang LY, Ma YF, Liang XG, Setterberg RB.
    J Bone Miner Res; 1995 Jan; 10(1):66-73. PubMed ID: 7747632
    [Abstract] [Full Text] [Related]

  • 17. Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats.
    Stolina M, Dwyer D, Niu QT, Villasenor KS, Kurimoto P, Grisanti M, Han CY, Liu M, Li X, Ominsky MS, Ke HZ, Kostenuik PJ.
    Bone; 2014 Oct; 67():305-13. PubMed ID: 25093263
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia.
    Ke HZ, Shen VW, Qi H, Crawford DT, Wu DD, Liang XG, Chidsey-Frink KL, Pirie CM, Simmons HA, Thompson DD.
    Bone; 1998 Sep; 23(3):249-55. PubMed ID: 9737347
    [Abstract] [Full Text] [Related]

  • 19. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats.
    Lauritzen DB, Balena R, Shea M, Seedor JG, Markatos A, Le HM, Toolan BC, Myers ER, Rodan GA, Hayes WC.
    J Bone Miner Res; 1993 Jul; 8(7):871-9. PubMed ID: 8352069
    [Abstract] [Full Text] [Related]

  • 20. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD.
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.